Post Approval Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem

Status unconfirmed

Conditions studied: Osteoarthritis

In brief

This is a prospective, single arm, multi-center, post-approval study designed to evaluate the short and long term clinical performance and safety in subjects receiving primary total hip arthroplasty (THA) with the U-Motion II+ Acetabular System and UTF Reduced Stem.

Key facts

Study ID
NCT02761499
Run by
United Orthopedic Corporation
People needed
200
Starts
2016-01-01
Expected to finish
2025-08-01
Last updated by the study team
2023-06-05

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.